Cite
MLA Citation
Raushan T. Kurmasheva et al.. “In vivo evaluation of the lysine‐specific demethylase (KDM1A/LSD1) inhibitor SP‐2577 (Seclidemstat) against pediatric sarcoma preclinical models: A report from the Pediatric Preclinical Testing Consortium (PPTC).” Pediatric blood & cancer, vol. 68, no. 11, 2021, p. n/a. http://access.bl.uk/ark:/81055/vdc_100142334666.0x000022